Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed CFO
Inv. presentation
Quarterly results
Cytosorbents Corp (CTSO) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Quarterly results
08/11/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
08/01/2023 8-K Quarterly results
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/19/2023 8-K Quarterly results
07/11/2023 8-K Quarterly results
07/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial"
06/07/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/02/2023 8-K Quarterly results
05/02/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/26/2023 8-K Quarterly results
04/21/2023 ARS Form ARS - Annual Report to Security Holders:
04/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/20/2023 8-K Quarterly results
04/06/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Consulting Agreement"
03/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "CytoSorbents Reports Fourth Quarter and Full Year 2022 Results"
03/09/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G/A AVENIR CORP reports a 5.6% stake in CytoSorbents Corporation
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 4.5% stake in CytoSorbents Corp.
02/07/2023 SC 13G Skylands Capital, LLC reports a 5.8% stake in CytoSorbents Corporation
12/29/2022 8-K Quarterly results
11/16/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/06/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
08/11/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/02/2022 8-K Quarterly results
Docs: "CytoSorbents Reports Second Quarter 2022 Financial and Operational Results PRINCETON, N.J., August 2, 2022 — CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today reported unaudited financial and operating results for the quarter ended June 30, 2022. Second Quarter 2022 Financial Results",
"CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms"
08/02/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/27/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/08/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy